The new bedside monitor has been designed to meet the needs of ambulatory surgery and specialty centers.

The new monitor can spot real-time mini trends for early detection of vital sign variability during outpatient procedures.

It will also work with the firm’s One Mainstream CO2 sensor kit, which is claimed to be the world’s first wearable mainstream CO2 sensor for non-intubated patients.

According to the company, the new monitor will integrate with electronic medical records systems.

Nihon Kohden America CEO Wilson Constantine said: “Hospitals and health systems know that not every patient requires intensive care or use of a high-acuity bed, but they also know patients in low-acuity areas still need to be monitored, no matter how minor a procedure may seem.

“By using Nihon Kohden’s line of quality, reliable monitors that are developed with our premium-as-standard philosophy, healthcare providers know their patients will be taken care of, no matter where they are in a health system.”

In April, the company also launched Life Scope G9 bedside monitor that enables clinicians to rapidly and easily customize to each patient regardless of health status or care setting.

Life Scope G9 provides inclusive monitoring capabilities, helping clinicians to oversee and track a comprehensive set of parameters across care areas.

With subsidiaries in the US, Europe and Asia, Nihon Kohden markets its medical electronic equipment in around 120 countries.